S100A8 and S100A9 are considered biomarkers of disease activity in chronic inflammatory pathologies associated with impaired matrix remodeling such as rheumatoid arthritis (RA), inflammatory bowel disease (IBD) and cystic fibrosis22. The gene discussed is S100A9; the disease is inflammatory bowel disease.